Delivery Order SPE2DR25D2101-SPE2DR26F48TR

<p>The Defense Logistics Agency issued a $1,824.00 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for Risperdal 0.5 mg tablets (60-count).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 12, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Risperdal 0.5 mg tablets (60-count) with a ceiling value of $1,094.40.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 25, 2026, and is priced on a firm fixed-price basis. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 2, 2026, for Risperdal 1 mg tablet UD 100s, with a ceiling value of $1,532.96, under firm fixed-price pricing.</p> <p>Place of performance is Conshohocken, PA. The order is due for completion by February 3, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Risperdal 0.5 mg tablets (60-count), with a ceiling value of $2,188.80. Place of performance is Conshohocken, PA. The ultimate completion date is February 18, 2026. This firm fixed-price delivery order was issued without a set-aside under a parent Indefinite Delivery Contract with the DLA Troop Support Medical that supports pharmaceutical supply to military healthcare programs globally.

The Defense Logistics Agency issued a $2,382.60 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Risperdal 3 mg tablets (60-count supply). Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of February 13, 2026. The delivery order was issued under the parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which supplies...

<p>The Defense Logistics Agency issued a $2,473.39 delivery order to Amerisourcebergen Drug Corp on February 13, 2026, for risperidone 2 mg tablets (60-count units), with ultimate completion by February 17, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed pricing and was awarded without set-aside on a competitive basis.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, with a ceiling value of $6,776.31 for risperidone 0.25 mg tablets (500-count supply).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 11, 2026. The order is priced on a firm fixed-price basis and carries no set-aside.</p>

<p>The Defense Logistics Agency issued a $10,745.05 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for 500 tablets of Risperidone 0.25 mg, with an ultimate completion date of February 11, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced firm fixed price and carries no set-aside designation.</p>

On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,892.49 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count package). This firm fixed-price delivery order is set to be completed by January 13, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, demonstrating the contractor's capability to meet federal...

The Defense Logistics Agency awarded a delivery order valued at $1,976.26 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count packages) under a firm fixed-price contract. The award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a competitively awarded, non-set-aside purchase order for pharmaceutical supply to support federal medical procurement needs. The contractor will perform from its corporate office location in...